Skip to main content
Top
Published in: Clinical Oral Investigations 3/2012

01-06-2012 | Original Article

Saliva in perimenopausal and early postmenopausal women. A 2-year follow-up study

Authors: Laura Tarkkila, Jussi Furuholm, Aila Tiitinen, Jukka H. Meurman

Published in: Clinical Oral Investigations | Issue 3/2012

Login to get access

Abstract

This study aims to investigate salivary flow and biochemical constituents of menopausal-age women with the hypothesis that women using hormone therapy (HT) might present better saliva values than non-users. Two hundred HT users and 200 non-users were selected at random from a cohort study of 3,173 peri- and postmenopausal women and invited to a 2-year clinical follow-up study. Clinical examination with saliva sampling was made at baseline and 2 years later. Salivary total protein, albumin, and immunoglobulin (Ig) concentrations were analyzed. Final material included 106 consistent HT users and 55 non-users. Backward logistic regression analysis was made to determine the risk factors for higher or lower than medium salivary protein values. No difference was seen in salivary flow rate, total protein, and IgA values between baseline and follow-up measurements or between the groups. Albumin, IgG, and IgM concentrations were significantly lower in the 2-year samples of the HT group when compared with baseline. IgA and IgM values were higher in the non-HT 2-year samples when compared with the corresponding HT samples. The only significant explanatory factor for higher than median salivary albumin concentration was the number of teeth both at baseline and 2 years later. HT possibly improved epithelial integrity since the concentrations of serum components albumin, IgG, and IgM decreased during the follow-up. HT as such does not seem to affect saliva, although it may modify it. The clinical relevance of these results needs to be assessed in future studies.
Literature
1.
go back to reference Forabosco A, Criscuolo M, Coukos G, Uccelli E, Weinstein R, Spinato S, Botticelli A, Volpe A (1992) Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 73:570–574PubMedCrossRef Forabosco A, Criscuolo M, Coukos G, Uccelli E, Weinstein R, Spinato S, Botticelli A, Volpe A (1992) Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 73:570–574PubMedCrossRef
2.
go back to reference Hakeberg M, Berggren U, Hägglin C, Ahlqwist M (1997) Reported burning mouth symptoms among middle-aged and elderly women. Eur J Oral Sci 105:539–543PubMedCrossRef Hakeberg M, Berggren U, Hägglin C, Ahlqwist M (1997) Reported burning mouth symptoms among middle-aged and elderly women. Eur J Oral Sci 105:539–543PubMedCrossRef
3.
go back to reference Hatch JP, Rugh JD, Sakai S, Saunders MJ (2001) Is the use of exogenous estrogen associated with temporomandibular signs and symptoms? J Am Dent Assoc 132:319–326PubMed Hatch JP, Rugh JD, Sakai S, Saunders MJ (2001) Is the use of exogenous estrogen associated with temporomandibular signs and symptoms? J Am Dent Assoc 132:319–326PubMed
4.
go back to reference Wardrop RW, Hailes J, Burger H, Reade PC (1989) Oral discomfort at menopause. Oral Surg Oral Med Oral Pathol 67:535–540PubMedCrossRef Wardrop RW, Hailes J, Burger H, Reade PC (1989) Oral discomfort at menopause. Oral Surg Oral Med Oral Pathol 67:535–540PubMedCrossRef
5.
go back to reference Tarkkila L, Linna M, Tiitinen A, Lindqvist C, Meurman JH (2001) Oral symptoms at menopause-the role of hormone replacement therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:276–280PubMedCrossRef Tarkkila L, Linna M, Tiitinen A, Lindqvist C, Meurman JH (2001) Oral symptoms at menopause-the role of hormone replacement therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:276–280PubMedCrossRef
6.
go back to reference Tarkkila L, Furuholm J, Tiitinen A, Meurman JH (2008) Oral health in perimenopausal and early postmenopausal women from baseline to 2 years of follow-up with reference to hormone replacement therapy. Clin Oral Investig 12:271–277PubMedCrossRef Tarkkila L, Furuholm J, Tiitinen A, Meurman JH (2008) Oral health in perimenopausal and early postmenopausal women from baseline to 2 years of follow-up with reference to hormone replacement therapy. Clin Oral Investig 12:271–277PubMedCrossRef
7.
go back to reference Ben Aryeh H, Gottlieb I, Ish-Shalom S, David A, Szargel H, Laufer D (1996) Oral complaints related to menopause. Maturitas 24:185–189PubMed Ben Aryeh H, Gottlieb I, Ish-Shalom S, David A, Szargel H, Laufer D (1996) Oral complaints related to menopause. Maturitas 24:185–189PubMed
8.
go back to reference Eliasson L, Carlen A, Laine M, Birkhed D (2003) Minor gland and whole saliva in postmenopausal women using a low potency oestrogen (oestriol). Arch Oral Biol 48:511–517PubMedCrossRef Eliasson L, Carlen A, Laine M, Birkhed D (2003) Minor gland and whole saliva in postmenopausal women using a low potency oestrogen (oestriol). Arch Oral Biol 48:511–517PubMedCrossRef
9.
go back to reference Friedlander AH (2002) The physiology, medical management and oral implications of menopause. J Am Dent Assoc 133:73–81PubMed Friedlander AH (2002) The physiology, medical management and oral implications of menopause. J Am Dent Assoc 133:73–81PubMed
10.
go back to reference Hietala EL, Heikkinen J, Vaananen HK, Larmas M (1993) Effect of postmenopausal estrogen treatment on some diagnostic salivary variables. Ann N Y Acad Sci 694:286–288PubMedCrossRef Hietala EL, Heikkinen J, Vaananen HK, Larmas M (1993) Effect of postmenopausal estrogen treatment on some diagnostic salivary variables. Ann N Y Acad Sci 694:286–288PubMedCrossRef
11.
go back to reference Laine M, Leimola-Virtanen R (1996) Effect of hormone replacement therapy on salivary flow rate, buffer effect and pH on perimenopausal and postmenopausal women. Arch Oral Biol 41:91–96PubMedCrossRef Laine M, Leimola-Virtanen R (1996) Effect of hormone replacement therapy on salivary flow rate, buffer effect and pH on perimenopausal and postmenopausal women. Arch Oral Biol 41:91–96PubMedCrossRef
12.
go back to reference Leimola-Virtanen R, Helenius H, Laine M (1997) Hormone replacement therapy and some salivary antimicrobial factors in post- and perimenopausal women. Maturitas 27:145–151PubMedCrossRef Leimola-Virtanen R, Helenius H, Laine M (1997) Hormone replacement therapy and some salivary antimicrobial factors in post- and perimenopausal women. Maturitas 27:145–151PubMedCrossRef
13.
go back to reference Streckfus CF, Baur U, Brown LJ, Bacal C, Metter J, Nick T (1998) Effects of estrogen status and aging on salivary flow rates in healthy Caucasian women. Gerontology 44:32–39PubMedCrossRef Streckfus CF, Baur U, Brown LJ, Bacal C, Metter J, Nick T (1998) Effects of estrogen status and aging on salivary flow rates in healthy Caucasian women. Gerontology 44:32–39PubMedCrossRef
14.
go back to reference Agha-Hosseini F, Mirzaii-Dizgah I, Moghaddam PP, Akrad ZT (2007) Stimulated whole salivary flow rate and composition in menopausal women with oral dryness feeling. Oral Dis 13:320–323PubMedCrossRef Agha-Hosseini F, Mirzaii-Dizgah I, Moghaddam PP, Akrad ZT (2007) Stimulated whole salivary flow rate and composition in menopausal women with oral dryness feeling. Oral Dis 13:320–323PubMedCrossRef
15.
go back to reference Yalcin F, Gurgan S, Gurgan T (2005) The effect of menopause, hormone replacement therapy (HRT), alendronate (AL), and calcium supplementation on saliva. J Contemp Dent Pract 6:10–17PubMed Yalcin F, Gurgan S, Gurgan T (2005) The effect of menopause, hormone replacement therapy (HRT), alendronate (AL), and calcium supplementation on saliva. J Contemp Dent Pract 6:10–17PubMed
16.
go back to reference Eviö S, Tarkkila L, Sorsa T, Furuholm J, Välimäki M, Ylikorkala O, Tiitinen A, Meurman JH (2006) Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis. Oral Dis 12:187–193PubMedCrossRef Eviö S, Tarkkila L, Sorsa T, Furuholm J, Välimäki M, Ylikorkala O, Tiitinen A, Meurman JH (2006) Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis. Oral Dis 12:187–193PubMedCrossRef
17.
go back to reference Välimaa H, Savolainen S, Soukka T, Silvoniemi P, Mäkelä S, Kujari H, Gustafsson JA, Laine M (2004) Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol 180:55–62PubMedCrossRef Välimaa H, Savolainen S, Soukka T, Silvoniemi P, Mäkelä S, Kujari H, Gustafsson JA, Laine M (2004) Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol 180:55–62PubMedCrossRef
18.
go back to reference Avivi I, Avraham S, Koren-Michowitz M, Zuckerman T, Aviv A, Ofran Y, Benyamini N, Nagler A, Rowe JM, Nagler RM (2009) Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT. Bone Marrow Transplant 43:801–806PubMedCrossRef Avivi I, Avraham S, Koren-Michowitz M, Zuckerman T, Aviv A, Ofran Y, Benyamini N, Nagler A, Rowe JM, Nagler RM (2009) Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT. Bone Marrow Transplant 43:801–806PubMedCrossRef
19.
go back to reference Helenius LM, Meurman JH, Helenius I, Kari K, Hietanen J, Suuronen R, Hallikainen D, Kautiainen H, Leirisalo-Repo M, Lindqvist C (2005) Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand 63:284–293PubMedCrossRef Helenius LM, Meurman JH, Helenius I, Kari K, Hietanen J, Suuronen R, Hallikainen D, Kautiainen H, Leirisalo-Repo M, Lindqvist C (2005) Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand 63:284–293PubMedCrossRef
20.
go back to reference Hirasaki S, Yamazaki T, Shiba K (2005) Changes in salivary components by drug administration in patients with heart diseases. J Med Dent Sci 52:183–188PubMed Hirasaki S, Yamazaki T, Shiba K (2005) Changes in salivary components by drug administration in patients with heart diseases. J Med Dent Sci 52:183–188PubMed
21.
go back to reference Vesterinen M, Ruokonen H, Leivo T, Honkanen AM, Honkanen E, Kari K, Lindqvist C, Meurman JH (2007) Oral health and dental treatment of patients with renal disease. Quintessence Int 38:211–219PubMed Vesterinen M, Ruokonen H, Leivo T, Honkanen AM, Honkanen E, Kari K, Lindqvist C, Meurman JH (2007) Oral health and dental treatment of patients with renal disease. Quintessence Int 38:211–219PubMed
22.
go back to reference Meurman JH, Rantonen P (1994) Salivary flow rate, buffering capacity, and yeast counts in 187 consecutive adult patients from Kuopio, Finland. Scand J Dent Res 102:229–234PubMed Meurman JH, Rantonen P (1994) Salivary flow rate, buffering capacity, and yeast counts in 187 consecutive adult patients from Kuopio, Finland. Scand J Dent Res 102:229–234PubMed
23.
go back to reference Webster D (1977) The immediate reaction between bromcresol green and serum as a measure of albumin content. Clin Chem 23:663–665PubMed Webster D (1977) The immediate reaction between bromcresol green and serum as a measure of albumin content. Clin Chem 23:663–665PubMed
24.
go back to reference Lehtonen OP, Grahn EM, Stahlberg TH, Laitinen LA (1984) Amount and avidity of salivary and serum antibodies against Streptococcus mutans in two groups of human subjects with different dental caries susceptibility. Infect Immun 43:308–313PubMed Lehtonen OP, Grahn EM, Stahlberg TH, Laitinen LA (1984) Amount and avidity of salivary and serum antibodies against Streptococcus mutans in two groups of human subjects with different dental caries susceptibility. Infect Immun 43:308–313PubMed
25.
go back to reference Mellanen L, Sorsa T, Lahdevirta J, Helenius M, Kari K, Meurman JH (2001) Salivary albumin, total protein, IgA, IgG and IgM concentrations and occurrence of some periodontopathogens in HIV-infected patients: a 2-year follow-up study. J Oral Pathol Med 30:553–559PubMedCrossRef Mellanen L, Sorsa T, Lahdevirta J, Helenius M, Kari K, Meurman JH (2001) Salivary albumin, total protein, IgA, IgG and IgM concentrations and occurrence of some periodontopathogens in HIV-infected patients: a 2-year follow-up study. J Oral Pathol Med 30:553–559PubMedCrossRef
26.
go back to reference Sewon L, Laine M, Karjalainen S, Leimola-Virtanen R, Hiidenkari T, Helenius H (2000) The effect of hormone replacement therapy on salivary calcium concentrations in menopausal women. Arch Oral Biol 45:201–206PubMedCrossRef Sewon L, Laine M, Karjalainen S, Leimola-Virtanen R, Hiidenkari T, Helenius H (2000) The effect of hormone replacement therapy on salivary calcium concentrations in menopausal women. Arch Oral Biol 45:201–206PubMedCrossRef
27.
go back to reference Meurman JH, Rantonen P, Pajukoski H, Sulkava R (2002) Salivary albumin and other constituents and their relation to oral and general health in the elderly. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:432–438PubMedCrossRef Meurman JH, Rantonen P, Pajukoski H, Sulkava R (2002) Salivary albumin and other constituents and their relation to oral and general health in the elderly. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:432–438PubMedCrossRef
28.
go back to reference Pisanty S, Rafaely B, Polishuk W (1975) The effect of steroid hormones on buccal mucosa of menopausal women. Oral Surg Oral Med Oral Pathol 40:346–353PubMedCrossRef Pisanty S, Rafaely B, Polishuk W (1975) The effect of steroid hormones on buccal mucosa of menopausal women. Oral Surg Oral Med Oral Pathol 40:346–353PubMedCrossRef
29.
go back to reference Nagler RM, Hershkovich O (2005) Relationships between age, drugs, oral sensorial complaints and salivary profile. Arch Oral Biol 50:7–16PubMedCrossRef Nagler RM, Hershkovich O (2005) Relationships between age, drugs, oral sensorial complaints and salivary profile. Arch Oral Biol 50:7–16PubMedCrossRef
30.
go back to reference Johnson RB (2005) Racial differences in salivary sIgA concentrations in postmenopausal women. Spec Care Dentist 25:145–149PubMedCrossRef Johnson RB (2005) Racial differences in salivary sIgA concentrations in postmenopausal women. Spec Care Dentist 25:145–149PubMedCrossRef
31.
go back to reference Dawes C (1987) Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 66:648–653PubMed Dawes C (1987) Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 66:648–653PubMed
32.
go back to reference Chatterton RT Jr, Mateo ET, Hou N, Rademaker AW, Acharya S, Jordan VC, Morrow M (2005) Characteristics of salivary profiles of oestradiol and progesterone in premenopausal women. J Endocrinol 186:77–84PubMedCrossRef Chatterton RT Jr, Mateo ET, Hou N, Rademaker AW, Acharya S, Jordan VC, Morrow M (2005) Characteristics of salivary profiles of oestradiol and progesterone in premenopausal women. J Endocrinol 186:77–84PubMedCrossRef
33.
go back to reference Ostrowska Z, Kos-Kudla B, Marek B, Swietochowska E, Gorski J (2001) Assessment of the relationship between circadian variations of salivary melatonin levels and type I collagen metabolism in postmenopausal obese women. Neuro Endocrinol Lett 22:121–127PubMed Ostrowska Z, Kos-Kudla B, Marek B, Swietochowska E, Gorski J (2001) Assessment of the relationship between circadian variations of salivary melatonin levels and type I collagen metabolism in postmenopausal obese women. Neuro Endocrinol Lett 22:121–127PubMed
34.
go back to reference Tivis LJ, Richardson MD, Peddi E, Arjmandi B (2005) Saliva versus serum estradiol: implications for research studies using postmenopausal women. Progr Neuro Psychopharmacol Biol Psychiatr 29:727–732CrossRef Tivis LJ, Richardson MD, Peddi E, Arjmandi B (2005) Saliva versus serum estradiol: implications for research studies using postmenopausal women. Progr Neuro Psychopharmacol Biol Psychiatr 29:727–732CrossRef
35.
go back to reference Patacchioli FR, Simeoni S, Monnazzi P, Pace M, Capri O, Perrone G (2006) Menopause, mild psychological stress and salivary cortisol: influence of long-term hormone replacement therapy (HT). Maturitas 55:150–155PubMedCrossRef Patacchioli FR, Simeoni S, Monnazzi P, Pace M, Capri O, Perrone G (2006) Menopause, mild psychological stress and salivary cortisol: influence of long-term hormone replacement therapy (HT). Maturitas 55:150–155PubMedCrossRef
36.
go back to reference Flink H, Tegelberg Å, Lagerlöf F (2005) Influence of the time of measurement of unstimulated human whole saliva on the diagnosis of hyposalivation. Arch Oral Biol 50:553–559PubMedCrossRef Flink H, Tegelberg Å, Lagerlöf F (2005) Influence of the time of measurement of unstimulated human whole saliva on the diagnosis of hyposalivation. Arch Oral Biol 50:553–559PubMedCrossRef
37.
go back to reference Laine M, Pienihakkinen K, Leimola-Virtanen R (1999) The effect of repeated sampling on paraffin-stimulated salivary flow rates in menopausal women. Arch Oral Biol 44:93–95PubMedCrossRef Laine M, Pienihakkinen K, Leimola-Virtanen R (1999) The effect of repeated sampling on paraffin-stimulated salivary flow rates in menopausal women. Arch Oral Biol 44:93–95PubMedCrossRef
Metadata
Title
Saliva in perimenopausal and early postmenopausal women. A 2-year follow-up study
Authors
Laura Tarkkila
Jussi Furuholm
Aila Tiitinen
Jukka H. Meurman
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Clinical Oral Investigations / Issue 3/2012
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-011-0573-4

Other articles of this Issue 3/2012

Clinical Oral Investigations 3/2012 Go to the issue